Literature DB >> 10436347

Neurochemical features of frontotemporal dementia.

A W Procter1, M Qurne, P T Francis.   

Abstract

This study examines neurochemical measures of cholinergic, serotonergic and glutamatergic innervation in frontal temporal and parietal cerebral cortex from 16 subjects with frontotemporal dementia (FTD) including 10 subjects with Pick pathology and 6 with dementia of frontal lobe type (DFT) together with 9 subjects with Alzheimer's disease, and 28 matched controls. In both forms of FTD there was not evidence of any cholinergic abnormality, unlike the situation in AD. Serotonin receptors were lost from frontal and temporal cortex in FTD and from temporal and parietal cortex in AD. In FTD there was no loss of kainate receptors but loss of AMPA receptors from both temporal and frontal lobes. Loss of AMPA receptors differentiated Pick-type FTD from DFT. These results are interpreted to indicate selective losses of subpopulations of cortical pyramidal neurones.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10436347     DOI: 10.1159/000051219

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  30 in total

Review 1.  Treatment approaches to symptoms associated with frontotemporal degeneration.

Authors:  Tiffany W Chow
Journal:  Curr Psychiatry Rep       Date:  2005-10       Impact factor: 5.285

Review 2.  Neuropsychological differences between frontotemporal dementia and Alzheimer's disease: a review.

Authors:  Michal Harciarek; Krzysztof Jodzio
Journal:  Neuropsychol Rev       Date:  2005-09       Impact factor: 7.444

Review 3.  Abhorring the vacuum: use of Alzheimer’s disease medications in frontotemporal dementia.

Authors:  Geoffrey A Kerchner; Maria Carmela Tartaglia; Adam Boxer
Journal:  Expert Rev Neurother       Date:  2011-05       Impact factor: 4.618

Review 4.  [Frontotemporal dementias].

Authors:  K Witt; G Deuschl; T Bartsch
Journal:  Nervenarzt       Date:  2013-01       Impact factor: 1.214

5.  Temporoparietal hypometabolism in frontotemporal lobar degeneration and associated imaging diagnostic errors.

Authors:  Kyle B Womack; Ramon Diaz-Arrastia; Howard J Aizenstein; Steven E Arnold; Nancy R Barbas; Bradley F Boeve; Christopher M Clark; Charles S DeCarli; William J Jagust; James B Leverenz; Elaine R Peskind; R Scott Turner; Edward Y Zamrini; Judith L Heidebrink; James R Burke; Steven T DeKosky; Martin R Farlow; Matthew J Gabel; Roger Higdon; Claudia H Kawas; Robert A Koeppe; Anne M Lipton; Norman L Foster
Journal:  Arch Neurol       Date:  2010-11-08

Review 6.  Therapy and clinical trials in frontotemporal dementia: past, present, and future.

Authors:  Richard M Tsai; Adam L Boxer
Journal:  J Neurochem       Date:  2016-06-15       Impact factor: 5.372

Review 7.  Frontotemporal lobar degeneration: epidemiology, pathophysiology, diagnosis and management.

Authors:  Gil D Rabinovici; Bruce L Miller
Journal:  CNS Drugs       Date:  2010-05       Impact factor: 5.749

8.  Brain atrophy in primary progressive aphasia involves the cholinergic basal forebrain and Ayala's nucleus.

Authors:  Stefan J Teipel; Wilhelm Flatz; Nibal Ackl; Michel Grothe; Ingo Kilimann; Arun L W Bokde; Lea Grinberg; Edson Amaro; Vanja Kljajevic; Eduardo Alho; Christina Knels; Anne Ebert; Helmut Heinsen; Adrian Danek
Journal:  Psychiatry Res       Date:  2013-12-06       Impact factor: 3.222

9.  [Frontotemporal dementia. Results from "Frontotemporal Demential and Pick's Disease Conference"].

Authors:  J Diehl; I R Mackenzie; H Förstl; A Kurz
Journal:  Nervenarzt       Date:  2003-05-10       Impact factor: 1.214

10.  Imbalance of a serotonergic system in frontotemporal dementia: implication for pharmacotherapy.

Authors:  D M Bowen; A W Procter; D M A Mann; J S Snowden; M M Esiri; D Neary; P T Francis
Journal:  Psychopharmacology (Berl)       Date:  2007-11-18       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.